183 related articles for article (PubMed ID: 30258155)
1. Immunotherapy offers a promising bet against brain cancer.
Eisenstein M
Nature; 2018 Sep; 561(7724):S42-S44. PubMed ID: 30258155
[No Abstract] [Full Text] [Related]
2. Vaccine strategies for glioblastoma: progress and future directions.
Jackson C; Ruzevick J; Brem H; Lim M
Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
[TBL] [Abstract][Full Text] [Related]
3. [Peptide vaccination in glioblastoma].
Terasaki M; Morioka M
Gan To Kagaku Ryoho; 2014 Jun; 41(6):725-9. PubMed ID: 25167577
[No Abstract] [Full Text] [Related]
4. Clinical applications of a peptide-based vaccine for glioblastoma.
Kanaly CW; Ding D; Heimberger AB; Sampson JH
Neurosurg Clin N Am; 2010 Jan; 21(1):95-109. PubMed ID: 19944970
[TBL] [Abstract][Full Text] [Related]
5. Early-stage progress on glioma vaccines.
Brower V
J Natl Cancer Inst; 2011 Sep; 103(18):1361-2. PubMed ID: 21881038
[No Abstract] [Full Text] [Related]
6. Dendritic cell immunotherapy for glioblastoma.
Polyzoidis S; Ashkan K
Expert Rev Anticancer Ther; 2014 Jul; 14(7):761-3. PubMed ID: 24850137
[TBL] [Abstract][Full Text] [Related]
7. Immunologic therapies for gastrointestinal cancers.
Levy B; Deeken JF; Holt G; Marshall JL
Clin Colorectal Cancer; 2005 May; 5(1):37-49. PubMed ID: 15929805
[TBL] [Abstract][Full Text] [Related]
8. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
Van Gool S; De Vleeschouwer S
Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731
[No Abstract] [Full Text] [Related]
9. The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients.
Paff M; Alexandru-Abrams D; Hsu FP; Bota DA
Hum Vaccin Immunother; 2014; 10(11):3322-31. PubMed ID: 25625931
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines in glioma: how to balance the challenges of small trials, efficiency, and potential adverse events.
Lowenstein PR
J Clin Oncol; 2010 Nov; 28(31):4670-3. PubMed ID: 20921460
[No Abstract] [Full Text] [Related]
11. Cancer vaccines: an update.
Hipp JD; Hipp JA; Lyday BW; Minev BR
In Vivo; 2000; 14(5):571-85. PubMed ID: 11125541
[TBL] [Abstract][Full Text] [Related]
12. Peptide vaccine.
Izumoto S
Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167
[TBL] [Abstract][Full Text] [Related]
13. Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas.
Del Vecchio CA; Li G; Wong AJ
Expert Rev Vaccines; 2012 Feb; 11(2):133-44. PubMed ID: 22309662
[TBL] [Abstract][Full Text] [Related]
14. [III. Peptide vaccination therapy against brain tumors].
Hashimoto N; Kagawa N; Arita H; Tsuboi A; Oka Y; Oji Y; Sugiyama H; Yoshimine T
Gan To Kagaku Ryoho; 2015 Jun; 42(6):687-9. PubMed ID: 26242006
[No Abstract] [Full Text] [Related]
15. Immunotherapy for glioblastoma: the devil is in the details.
Lesniak MS
J Clin Oncol; 2011 Aug; 29(22):3105; author reply 3105-6. PubMed ID: 21709193
[No Abstract] [Full Text] [Related]
16. Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.
Khansur E; Shah AH; Lacy K; Komotar RJ
Cancer Invest; 2019; 37(1):1-7. PubMed ID: 30632816
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for high-grade glioma.
Dixit S
Future Oncol; 2014 May; 10(6):911-5. PubMed ID: 24941977
[TBL] [Abstract][Full Text] [Related]
18. Heat shock proteins in glioblastomas.
Yang I; Fang S; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell vaccines to combat glioblastoma.
Wheeler CJ
Expert Rev Neurother; 2010 Apr; 10(4):483-6. PubMed ID: 20367199
[No Abstract] [Full Text] [Related]
20. First results on the DCVax phase III trial: raising more questions than providing answers.
Wick W; van den Bent MJ
Neuro Oncol; 2018 Sep; 20(10):1283-1284. PubMed ID: 30137551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
